Cargando…

Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Harrison, Taylor, Fillet, Morgan, Renteria, Anne, Williams, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202742/
http://dx.doi.org/10.1016/S2666-6367(22)00736-9
_version_ 1785045490282266624
author Harrison, Taylor
Fillet, Morgan
Renteria, Anne
Williams, James
author_facet Harrison, Taylor
Fillet, Morgan
Renteria, Anne
Williams, James
author_sort Harrison, Taylor
collection PubMed
description
format Online
Article
Text
id pubmed-10202742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-102027422023-05-23 Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic Harrison, Taylor Fillet, Morgan Renteria, Anne Williams, James Transplant Cell Ther Poster Session - Quality and Transplant Program Administration (For Administrative Director Track) American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC10202742/ http://dx.doi.org/10.1016/S2666-6367(22)00736-9 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Session - Quality and Transplant Program Administration (For Administrative Director Track)
Harrison, Taylor
Fillet, Morgan
Renteria, Anne
Williams, James
Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title_full Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title_fullStr Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title_full_unstemmed Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title_short Are We Crazy? Building a Successful Acute Leukemia and Stem Cell Transplant Program during the COVID-19 Pandemic
title_sort are we crazy? building a successful acute leukemia and stem cell transplant program during the covid-19 pandemic
topic Poster Session - Quality and Transplant Program Administration (For Administrative Director Track)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202742/
http://dx.doi.org/10.1016/S2666-6367(22)00736-9
work_keys_str_mv AT harrisontaylor arewecrazybuildingasuccessfulacuteleukemiaandstemcelltransplantprogramduringthecovid19pandemic
AT filletmorgan arewecrazybuildingasuccessfulacuteleukemiaandstemcelltransplantprogramduringthecovid19pandemic
AT renteriaanne arewecrazybuildingasuccessfulacuteleukemiaandstemcelltransplantprogramduringthecovid19pandemic
AT williamsjames arewecrazybuildingasuccessfulacuteleukemiaandstemcelltransplantprogramduringthecovid19pandemic